Want to join the conversation?
Weston, MA-based biotech firm $BIIB posted 1Q16 sales of $2.7Bil, up 7% YoverY, driven by increased revenues from TECFIDERA, ELOCTATE and ALPROLIX. For the quarter, net income attributable to $BIIB was $971MM, or $4.43 per diluted share, up 18% from $823MM, or $3.49 per diluted share, in the prior year quarter.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.